Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime
NCT02533960
Brain Diseases, Cardiovascular Diseases
Heidelberg, Germany
View Trial DetailsNCT Number: NCT01036646
This multi-center study is designed to evaluate the ability of intended lay users (patients on oral anticoagulation therapy, OAT, or their caregivers) to 1) operate the INRatio Prothrombin Time (PT) Monitoring System utilizing the INRatio test strip newly designed for low sample volume and heparin insensitivity, and 2) obtain accurate results for the quantitative determination of International Normalized Ratio (INR) when self-testing using fingerstick capillary blood. Patients will be trained by their healthcare provider using the instructions for use and product labeling provided. The accuracy of the patient INR results will be assessed by comparison to the INR results obtained by the site's trained healthcare professional using the same INRatio system (from a separate fingerstick collected from the same patient at the point-of-care), and with the INR results obtained on venous plasma obtained from the same patient and analyzed at a central laboratory with the Sysmex CA-560 System INR reference method.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Loma Linda VA Hospital, Loma Linda, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 8 weeks
Abbott RDx Cardiometabolic
Other
Acronym: ECLIPSE-02
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02533960
Brain Diseases, Cardiovascular Diseases
Heidelberg, Germany
View Trial DetailsNCT02067182
Arrhythmias, Cardiac, Atrial Fibrillation
Bad Krozingen, Germany
View Trial DetailsNCT04307225
Arrhythmias, Cardiac, Atrial Fibrillation
Örebro, Sweden
View Trial DetailsNCT00603317
Arrhythmias, Cardiac, Atrial Fibrillation
Paris, France
View Trial Details